1. Academic Validation
  2. Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase

Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase

  • J Med Chem. 1995 May 12;38(10):1657-65. doi: 10.1021/jm00010a010.
P G Wyatt 1 R C Bethell N Cammack D Charon N Dodic B Dumaitre D N Evans D V Green P L Hopewell D C Humber
Affiliations

Affiliation

  • 1 Medicinal Chemistry Department, Glaxo Research and Development Limited, Glaxo Medicines Research Centre, Stevenage, Herts, U.K.
Abstract

A series of benzophenone derivatives has been synthesized and evaluated as inhibitors of HIV-1 Reverse Transcriptase (RT) and the growth of HIV-1 in MT-4 cells. Through the use of the structure-activity relationships within this series of compounds and computational chemistry techniques, a binding conformation is proposed. The SAR also indicated that the major interactions of 1h with the RT enzyme are through hydrogen bonding of the amide and benzophenone carbonyls and pi-orbital interactions with the benzophenone nucleus and an aromatic function separated from the benzophenone by a suitable spacer group. The crystal structure of compound 1h has been determined. A number of compounds with potent inhibitory activity against HIV-1 RT and HIV in cellular assays at levels comparable with AZT and our efforts to identify a metabolically stable analogue are described.

Figures